参考文献/References:
[1]Liang Y,Zhang H,Song X,et al.Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets[J].Semin Cancer Biol,2020,60:14-27.[2]Wu Q,Li J,Zhu S,et al.Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study[J].Oncotarget,2017,8(17):27990-27996.[3]Cardoso F,Paluch-Shimon S,Senkus E,et al.5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)[J].Ann Oncol,2020,31(12):1623-1649.[4]Niu L,Lv H,Zhang M,et al.Clinical diagnosis and treatment of breast cancer with brain metastases and establishment of a prognostic model: a 10-year,single-center,real-world study of 559 cases[J].Ann Transl Med,2021,9(16):1331.[5]Lin M,Jin Y,Jin J,et al.A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer[J].Cancer Med,2020,9(22):8540-8551.[6]Sun MS,Liu YH,Ye JM,et al.A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer[J].Ann Transl Med,2021,9(10):853.[7]Koniali L,Hadjisavvas A,Constantinidou A,et al.Risk factors for breast cancer brain metastases: a systematic review[J].Oncotarget,2020,11(6):650-669.[8]Wang H,Zhang C,Zhang J,et al.The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study[J].Oncotarget,2017,8(16):26368-26379.[9]Lee KL,Chen G,Chen TY,et al.Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions[J].Cancers (Basel),2020,12(8):2122.[10]Bastos DCA,Maldaun MVC,Sawaya R,et al.Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era[J].Neurooncol Pract,2018,5(3):161-169.[11]Rostami R,Mittal S,Rostami P,et al.Brain metastasis in breast cancer:a comprehensive literature review[J].J Neurooncol,2016,127(3):407-414.[12]Bryan S,Witzel I,Borgmann K,et al.Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers[J].Cancers (Basel),2021,13(16):4137.[13]Yang H,Wang R,Zeng F,et al.Impact of molecular subtypes on metastatic behavior and overall survival in patients with metastatic breast cancer: A single-center study combined with a large cohort study based on the Surveillance,Epidemiology and End Results database[J].Oncol Lett,2020,20(4):87.[14]Izutsu N,Kinoshita M,Ozaki T,et al.Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases[J].Mol Clin Oncol,2021,15(3):175.[15]Sun B,Huang Z,Wu S,et al.Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer[J].Radiother Oncol,2016,118(1):181-186.[16]Hosonaga M,Saya H,Arima Y.Molecular and cellular mechanisms underlying brain metastasis of breast cancer[J].Cancer Metastasis Rev,2020,39(3):711-720.[17]Wang S,Liang K,Hu Q,et al.JAK2-binding long noncoding RNA promotes breast cancer brain metastasis[J].J Clin Invest,2017,127(12):4498-4515.[18]Xing F,Liu Y,Wu SY,et al.Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis[J].Cancer Res,2018,78(15):4316-4330.[19]Wu SY,Sharma S,Wu K,et al.Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions[J].Breast Cancer Res,2021,23(1):35.[20]Mustafa DAM,Pedrosa RMSM,Smid M,et al.T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression[J].Acta Neuropathol,2018,135(4):581-599.[21]Pan JK,Lin CH,Kuo YL,et al.MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer[J].Oncogene,2021,40(9):1737-1751.[22]Yuan F,Wang W,Cheng H.Co-expression network analysis of gene expression profiles of HER2+ breast cancer-associated brain metastasis[J].Oncol Lett,2018,16(6):7008-7019.[23]Wu F,McCuaig RD,Sutton CR,et al.Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer[J].Int J Mol Sci,2019,20(12):3080.[24]Ren D,Zhu X,Kong R,et al.Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer[J].Cancer Res,2018,78(8):2052-2064.[25]Dong T,Liu Z,Xuan Q,et al.Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis[J].Sci Rep,2017,7(1):6069.[26]Bergen ES,Berghoff AS,Steindl A,et al.Androgen Receptor is Expressed in Breast Cancer Brain Metastases[J].Appl Immunohistochem Mol Morphol,2021,29(10):728-733.[27]Guedes de Castro D,Braun AC,Calsavara VF,et al.Prospective Assessment of the Association Between Circulating Tumor Cells and Control of Brain Disease After Focal Radiation Therapy of Breast Cancer Brain Metastases[J].Adv Radiat Oncol,2021,6(2):100673.[28]Zhu L,Chen M,Huang B,et al.Genomic Analysis Uncovers Immune Microenvironment Characteristics and Drug Sensitivity of Ferroptosis in Breast Cancer Brain Metastasis[J].Front Genet,2022,12:819632.[29]Meng Y,Reilly RM,Pezo RC,et al.MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases[J].Sci Transl Med,2021,13(615):eabj4011.[30]Blazquez R,Wlochowitz D,Wolff A,et al.PI3K: A master regulator of brain metastasis-promoting macrophages/microglia[J].Glia,2018,66(11):2438-2455.[31]Xu F,Xia Y,Feng Z,et al.Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases[J].Am J Cancer Res,2019,9(3):459-478.[32]Feng Z,Xia Y,Gao T,et al.The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis[J].Cell Death Dis,2018,9(10):1006.[33]Zhao J,Yang Y,Pang D,et al.Development and validation of a nomogram in survival prediction among advanced breast cancer patients[J].Ann Transl Med,2020,8(21):1446.[34]Leone JP,Haraldsson B,Mott SL,et al.Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases[J].Am J Clin Oncol,2019,42(1):60-66.[35]Kim JM,Miller JA,Kotecha R,et al.Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis[J].Neuro Oncol,2019,21(5):659-668.[36]Li Y,Su P,Wang Y,et al.Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer[J].Cancer Med,2020,9(3):872-881.[37]Wang R,Zhu Y,Liu X,et al.The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer[J].BMC Cancer,2019,19(1):1091.[38]Xiong Y,Cao H,Zhang Y,et al.Nomogram-Predicted Survival of Breast Cancer Brain Metastasis:a SEER-Based Population Study[J].World Neurosurg,2019,128:823-834.[39]Hou L,Qiu M,Chen M,et al.The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database[J].Gland Surg,2021,10(6):1889-1898.[40]Liu Q,Kong X,Wang Z,et al.NCCBM,a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis[J].Front Oncol,2021,11:642-677.[41]Zimmerman BS,Seidman D,Cascetta KP,et al.Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis[J].Oncology,2021,99(5):280-291.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(03):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Journal of Medical Information,2022,35(03):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]吴 倩,王一非.中西医结合治疗肺癌脑转移疗效与安全性的Meta分析[J].医学信息,2022,35(10):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
WU Qian,WANG Yi-fei.Meta-analysis of Efficacy and Safety of Integrated Traditional Chinese and Western Medicine in the Treatment of Brain Metastasis of Lung Cancer[J].Journal of Medical Information,2022,35(03):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
[5]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(03):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[6]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Journal of Medical Information,2022,35(03):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[7]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Journal of Medical Information,2019,32(03):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[8]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Journal of Medical Information,2019,32(03):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[9]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(03):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[10]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Journal of Medical Information,2019,32(03):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]